Mengis Capital Management Inc. lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 8.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,703 shares of the company's stock after selling 1,680 shares during the period. Mengis Capital Management Inc.'s holdings in Procter & Gamble were worth $2,820,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Stableford Capital II LLC increased its stake in shares of Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock valued at $993,000 after buying an additional 61 shares during the period. Bernard Wealth Management Corp. grew its stake in Procter & Gamble by 20.2% in the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock valued at $64,000 after purchasing an additional 63 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management grew its stake in Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock valued at $476,000 after purchasing an additional 63 shares during the last quarter. Private Management Group Inc. grew its stake in Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock valued at $236,000 after purchasing an additional 64 shares during the last quarter. Finally, Lantz Financial LLC grew its stake in Procter & Gamble by 1.2% in the second quarter. Lantz Financial LLC now owns 5,237 shares of the company's stock valued at $834,000 after purchasing an additional 64 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Activity
In related news, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares of the company's stock, valued at $48,703,248.36. The trade was a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the business's stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares of the company's stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the company. BNP Paribas reiterated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Berenberg Bank lifted their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Barclays cut their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 1st. JPMorgan Chase & Co. cut their target price on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a research note on Friday. Finally, UBS Group dropped their price target on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a research note on Wednesday. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $172.21.
View Our Latest Report on PG
Procter & Gamble Trading Down 0.6%
Procter & Gamble stock opened at $149.69 on Friday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52 week low of $149.45 and a 52 week high of $180.43. The company has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 3.99 and a beta of 0.36. The stock has a 50-day moving average price of $155.24 and a 200 day moving average price of $159.53.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the company posted $1.40 earnings per share. The company's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.